Starting July 1, Medicare beneficiaries who qualify will have access to GLP-1 drugs for weight loss at $50 per month, marking the first time the federal insurance program covers the medications for that purpose.
Experts say beneficiaries should carefully consider potential side effects and muscle loss before starting the drugs.
